Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by GeoEngineer on Apr 15, 2016 4:42pm

ok

there will be news, most likely not a jackpot positive news that makes you triple your investment, but somewhat a positive note to the complete shot down letter from FDA couple months ago--which i think was built into the shareprice it is trading today.

i hate when some " seasoned" traders all look down the "newbies" like you've been through enough s*h*i*t and you know the s*h*i*t...i may be new but i've probably been through enough s*h*i*t in life that i have accumulated more wealth than some of your cynical "seasoned" traders with your "smart" mind and trading " experience"

common sense and fundamentals always prevail, may not be today, may not be monday, but it will evantually slap the smart asses's faces
Comment by DamnYankees on Apr 15, 2016 4:56pm
Geo, you are probably trying to apply a scientific model to Telesta and determine that it is drastically undervalued. I get that and I appreciate your logical analysis. Yes this is the cheapest P3 on any exchange on Earth and yes it is a Phase 3 bladder cancer biotech that trades at less than cash value, yes it's treatment and trial were peer reviewed in the Journal of Urology, yes it ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities